A double-blind test of blue-blocking filters on symptoms of digital eye strain
- PMID: 32007978
- DOI: 10.3233/WOR-203086
A double-blind test of blue-blocking filters on symptoms of digital eye strain
Abstract
Background: Many ophthalmic lens manufacturers are currently marketing blue-blocking filters, which they claim will reduce symptoms of Digital Eye Strain (DES). However, there is limited evidence to support the proposal that DES results from the blue light emitted by electronic screens.
Objective: This investigation compared the effect of blue-blocking filters on DES symptoms with a no-filter lens, using a double-blind methodology.
Methods: Twenty-four subjects were required to perform a 20-minute reading task from a tablet computer. They wore either lenses containing a blue-blocking filter (TheraBlue 1.67 or TheraBlue polycarbonate) or a CR-39 control lens which did not include a filter. Immediately following each session, subjects completed a questionnaire to quantify symptoms of DES.
Results: While a significant increase in symptoms was observed immediately following the near vision task (p = 0.00001), no significant difference in symptoms was found between the 3 lens conditions (p = 0.74).
Conclusions: There is little evidence at this time to support the use of blue-blocking filters as a clinical treatment for DES. Management of other ocular factors, as well as the creation of an optimal environment for screen viewing, are more likely to provide greater success in minimizing symptoms.
Keywords: Blue-blocking filter; blue light; computer vision syndrome; digital eye strain; visual symptoms.
Similar articles
-
Blue-blocking Filters and Digital Eyestrain.Optom Vis Sci. 2019 Jan;96(1):48-54. doi: 10.1097/OPX.0000000000001318. Optom Vis Sci. 2019. PMID: 30570598
-
Do Blue-blocking Lenses Reduce Eye Strain From Extended Screen Time? A Double-Masked Randomized Controlled Trial.Am J Ophthalmol. 2021 Jun;226:243-251. doi: 10.1016/j.ajo.2021.02.010. Epub 2021 Feb 12. Am J Ophthalmol. 2021. PMID: 33587901 Clinical Trial.
-
An investigation of low power convex lenses (adds) for eyestrain in the digital age (CLEDA).J Optom. 2020 Jul-Sep;13(3):198-209. doi: 10.1016/j.optom.2019.12.006. Epub 2020 Apr 22. J Optom. 2020. PMID: 32334980 Free PMC article. Clinical Trial.
-
Digital eye strain in young screen users: A systematic review.Prev Med. 2023 May;170:107493. doi: 10.1016/j.ypmed.2023.107493. Epub 2023 Mar 26. Prev Med. 2023. PMID: 36977430 Review.
-
Ocular and visual discomfort associated with smartphones, tablets and computers: what we do and do not know.Clin Exp Optom. 2019 Sep;102(5):463-477. doi: 10.1111/cxo.12851. Epub 2019 Jan 21. Clin Exp Optom. 2019. PMID: 30663136 Review.
Cited by
-
Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults.Cochrane Database Syst Rev. 2023 Aug 18;8(8):CD013244. doi: 10.1002/14651858.CD013244.pub2. Cochrane Database Syst Rev. 2023. PMID: 37593770 Review.
-
Computer Vision Syndrome in Undergraduate and Medical Students During the COVID-19 Pandemic.Clin Ophthalmol. 2023 Apr 10;17:1087-1096. doi: 10.2147/OPTH.S405249. eCollection 2023. Clin Ophthalmol. 2023. PMID: 37064959 Free PMC article.
-
Blue Light Exposure: Ocular Hazards and Prevention-A Narrative Review.Ophthalmol Ther. 2023 Apr;12(2):755-788. doi: 10.1007/s40123-023-00675-3. Epub 2023 Feb 18. Ophthalmol Ther. 2023. PMID: 36808601 Free PMC article. Review.
-
Knowledge, attitude, and practice on digital eye strain during coronavirus disease-2019 lockdown: A comparative study.Oman J Ophthalmol. 2022 Nov 2;15(3):279-283. doi: 10.4103/ojo.ojo_135_21. eCollection 2022 Sep-Dec. Oman J Ophthalmol. 2022. PMID: 36760941 Free PMC article.
-
Effect of increased screen time on eyes during COVID-19 pandemic.J Family Med Prim Care. 2022 Jul;11(7):3642-3647. doi: 10.4103/jfmpc.jfmpc_2219_21. Epub 2022 Jul 22. J Family Med Prim Care. 2022. PMID: 36387628 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
